TERAPIAS COMBINADAS QUE USAN DERIVADOS DE INDAZOLILBENZAMIDA PARA EL TRATAMIENTO DEL CANCER.
- 专利权人:
- ESANEX; INC.
- 发明人:
- Everardus O. M. ORLEMANS
- 申请号：
- MX2018013863
- 公开号：
- MX2018013863A
- 申请日:
- 2017.05.18
- 申请国别(地区):
- MX
- 年份:
- 2019
- 代理人:
- 摘要：
- The invention relates to combination therapies useful in the treatment and/or prevention of cancer.La invención se refiere a terapias combinadas útiles en el tratamiento y/o en la prevención del cáncer.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- PROGRAMMING INTERFACE FOR SPINAL CORD NEUROMODULATION
- THE USE OF SILVER(I) COMPLEXES AS ACTIVE PHARMACEUTICAL INGREDIENTS (API'S) IINCLUDING ANTICANCER AGENTS
- PROGRAMMING INTERFACE WITH AN UNWRAPPED 2D VIEW OF A STIMULATION LEAD WITH COMPLEX ELECTRODE ARRAY GEOMETRY
- The compound with low oral bioavailability was precompressed and rapidly decomposed.
